If you are a current AONN+ member and this is the first time you are accessing our newly redesigned site, then you will need to update your password using the Forgot Password feature and complete the member profile section in order to proceed.

Improving Patient Care & Quality of Life

Join AONN+

Connect & Become a Member

An AONN+ Membership costs just $200 per year for all of these valuable benefits!

Access tools and resources for your patients and their caregivers through our members-only online resource center. AONN+ Members also receive a subscription to the Journal of Navigation & Survivorship™, The Oncology Nurse-APN/PA®, and Personalized Medicine in Oncology™ (digital version), a value of more than $1500 a year!

Learn More Become a Member

Start Today & Get Involved

Connect with nurse navigators close to home through our local AONN+ Chapters.

Exchange practice tips, find job opportunities, and get involved in community outreach initiatives that improve care in your region. Chapter leader should have experience with team building and have a personal commitment to wanting to promote education and career development of oncology navigators in his/her region.

Start a Chapter

Navigation & Survivorship

Register for the 2016 AONN+ East Coast Regional Meeting

Don’t miss our 2016 East Coast Regional Meeting in New Orleans, LA! Highlights will include networking opportunities, N.E.X.T. (Navigators Exploring Xtra Tracks) Day sessions, and discussions on the evolving challenges of program improvement, the role of personalized medicine, and implementing best practices in navigation, survivorship, and psychosocial care in the east coast regions.

Register Now Travel Grant

News: 2015 Conference Highlights

Day OneDay TwoDay ThreeDay Four

Oncology News

November 25th, 2015

European Commission approves Blincyto for acute lymphoblastic leukemia + read more

November 24th, 2015

Use of antivirals in retrovirus-infected cats + read more

November 24th, 2015

Genmab announces ofatumumab Phase III study in follicular lymphoma to be stopped following planned interim analysis + read more